← Back to Investors

Abingworth

One of the oldest life sciences venture capital firms in the world, with a transatlantic presence investing across therapeutics, diagnostics, and life science tools. Over 50 years of experience in life sciences investing.

Location
London, UK / Boston, USA
Founded
1973
AUM
$3B+
Investment Range
$5M - $50M
Portfolio Companies
34
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c, growth

Portfolio Companies

NameLocationFoundedCategories
Adicet BioRedwood City, California, USA-
cell-therapybiotech+3
AdvanCell---
Antares Therapeutics--
biotechtherapeutics
Ascend Advanced TherapiesRockville, Maryland, USA-
biotechgene-therapy+3
Attena--
biotechtherapeutics
AvillionLondon, United Kingdom2013
pharmaceuticaldrug-development+3
Cytospire Therapeutics--
biotechtherapeutics
Entact Bio--
biotechtherapeutics
ExicureChicago, Illinois, USA2012
biotechgenetic-medicine+2
GenSight BiologicsParis, France2012
gene-therapybiotech+2
GlycomineSan Carlos, California, USA2012
rare-diseasetherapeutics+2
HilleVaxCambridge, Massachusetts, USA2019
biotechvaccines+2
Jasper TherapeuticsRedwood City, California, USA2019
biotechstem-cell-transplant+2
Launch TherapeuticsSan Diego, California, USA2020
biotechtherapeutics+2
Median TechnologiesSophia Antipolis, France2002
healthcare-technologymedical-imaging+3
Nido BiosciencesBoston, Massachusetts, USA2019
biotechmicrobiome+3
Noveome BiotherapeuticsPittsburgh, Pennsylvania, USA2006
biotechregenerative-medicine+2
NuCanaEdinburgh, United Kingdom2008
oncologycancer-therapeutics+2
OnKure TherapeuticsBoulder, Colorado, USA2019
biotechoncology+2
OptheaMelbourne, Australia2007
biotechophthalmology+2
OrbusNeich MedicalHong Kong, China1996
medical-devicescardiovascular+1
Pathaly--
healthcarebiotech+1
Phathom PharmaceuticalsFlorham Park, New Jersey, USA2018
pharmaceuticalsgastroenterology+1
Q32 BioCambridge, Massachusetts, USA2018
biotechautoimmune+2
Solve TherapeuticsBoston, Massachusetts, USA2020
biotechtherapeutics+2
SoteriaUnited Kingdom-
biotechtherapeutics+1
Timberlyne TherapeuticsBoston, Massachusetts, USA2021
biotechtherapeutics+2
Tizona TherapeuticsSouth San Francisco, California, USA2014
biotechimmunotherapy+2
Trishula TherapeuticsUnited Kingdom-
biotechtherapeutics+1
Venatorx PharmaceuticalsMalvern, Pennsylvania, USA2010
biotechpharmaceuticals+2
WugenSt. Louis, Missouri, USA2018
biotechcell-therapy+2
Iambic TherapeuticsSan Diego, California, USA2019
therapeuticsdrug-discovery+2
Spruce BiosciencesDaly City, California, USA2016
therapeuticsbiotech+3
Myricx BioLondon, United Kingdom2019
therapeuticsbiotech+3